Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 11, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • pandemic
  • Page 6

Tag: pandemic

  • BiotechToday
  • World

Study reveals SARS-CoV-2 prevents the formation of new red blood cells

bioxone November 4, 2020November 3, 2020 1

Sumedha Guha, Techno India University In a recent study conducted on lung samples obtained from 79 patients who died of COVID-19, researchers from the Far Eastern Federal University in Russia discovered the SARS-CoV-2 virus can not only damage red blood cells (RBCs) but also prevent the new formation of key red blood cells (namely, Erythrocytes).  […]

Read More
  • BiotechToday
  • World

The Myth of ‘COVID-19 Curve Flattening’

bioxone November 3, 2020November 2, 2020

Chitra Roy, University of Calcutta Several months into the pandemic and the coronavirus is not only reaching into remote areas but also to regions that had previously been battered by the virus. This has led to a recent rise in the number of cases in the U.S. The last seven-day average for new cases is […]

Read More
  • BiotechToday
  • World

WILL COVID-19 VACCINE WORK?

bioxone October 31, 2020October 30, 2020 1

Chitra Roy, University of Calcutta As we are getting closer to the COVID-19 vaccine, it is exciting to think of the day when the virus will be gone. But, the COVID-19 vaccine will not be the magic bullet considering its efficacy and the challenges currently being faced in these efficacy studies. Efficacy of a vaccine […]

Read More
  • BiotechToday
  • World

One-pot Visual RT PCR as a diagnostic test for SARS-CoV-2

bioxone October 29, 2020October 28, 2020 1

Sumedha Guha, Techno India University The outbreak of the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) towards the latter part of 2019 had brought mankind to a screeching halt for some time. The global pandemic that followed in its wake is something that every nation of the world is still grappling hard to recover from. […]

Read More
  • BiotechToday
  • World

High Flow Nasal Cannula: A sigh of relief for fragile COVID-19 patients?

bioxone October 23, 2020October 23, 2020

-Sashreek Ganguli, Amity University Kolkata One- fifth of the COVID-19 patients in today’s world develop critical interstitial pneumonia characterized by bilateral interstitial infiltrates, leading to Acute Respiratory Distress Syndrome (ARDS) and respiratory failure. These patients while under treatment show acute hypoxemia and often have persistent dyspnea, despite the administration of oxygen flows>10–15l/min through a facial […]

Read More
  • BiotechToday
  • World

Is the pandemic interfering with the treatment for other diseases?

bioxone October 19, 2020October 19, 2020

Camelia Bhattacharyya, Amity University Kolkata The pandemic, that is, the COVID-19 pandemic hit the world all of a sudden, changing infection rates or rather increasing it every day without leaving the world to think of the ways to fight with the unknown enemy, the virus. This created a lot of panic at the beginning of […]

Read More
  • BiotechToday
  • World

COVID-19: Vaccine Development Probe

bioxone October 15, 2020October 15, 2020

Thota Kanishka Rao, Amity University Kolkata Emerged in 2019, and spread rapidly, the Coronavirus Disease 2019 (COVID-19) impacted economies worldwide, overwhelming health-care systems, as it infected millions causing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  To respond, a worldwide effort has been initiated to develop vaccines and therapeutic agents.  For COVID-19 vaccine development, the trimeric […]

Read More
  • BiotechToday
  • World

Herd Immunity Theory? – A Warning!! From WHO

bioxone October 14, 2020October 14, 2020

Samrat Sarkar, Amity University Kolkata  On this point when the entire world is on its way to find a way out to find a solution of the CORONA virus, scientists came up with an idea of ‘Herd Immunity’ theory which according to them would have been a big hit but on the other way WHO’s […]

Read More
  • BiotechToday
  • World

Cancer, COVID-19 and reconciling the Riddles

bioxone October 14, 2020October 14, 2020

Srilagna Sarkar, Amity University Kolkata Severe acute respiratory syndrome Coronavirus 2(SARS-CoV-2) and related to the Coronavirus disease as seen has led to a novel degree of disturbance globally. Whether oncology stakeholders, its patients, families or clinicians are adjusting and conforming with the challenges caused by the convergence of the two-life threatening diseases. Two studies by […]

Read More
  • BiotechToday
  • India
  • World

AstraZeneca: Late-stage trial of Covid-19 antibody medicine to start soon

bioxone October 12, 2020October 12, 2020

Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]

Read More

Posts navigation

1 2 3 4 5 6 7

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy